Kyle Helmerson, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 204 N Jefferson St, Mount Pleasant, IA 52641 Phone: 319-385-3000 |
Cox Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 520 S Grand Ave, Mount Pleasant, IA 52641 Phone: 563-468-1819 |
Dr. Jesse Lee Miller, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 520 S Grand Ave, Mount Pleasant, IA 52641 Phone: 319-385-1430 Fax: 319-385-1431 |
Shull Chiropractic Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 811 E Washington St, Mount Pleasant, IA 52641 Phone: 319-385-7320 Fax: 319-385-7322 |
Dr. Matthew G Shull, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 811 E Washington St, Mount Pleasant, IA 52641 Phone: 319-385-7320 Fax: 319-385-7322 |
Dr. Todd R Lange, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 520 S Grand Ave, Mount Pleasant, IA 52641 Phone: 319-385-1430 Fax: 319-385-1431 |
News Archive
Positron emission tomography has been successfully applied to an increasing number of cardiovascular conditions.
The Philadelphia Inquirer on Sunday examined the efficacy of Genomic Health's Oncotype DX test and Amsterdam, Netherlands-based Agendia's MammaPrint, both of which measure a woman's odds of breast cancer relapse by testing her removed tumor for genes that can predict the likelihood of her cancer returning.
A new software program effectively brings the expertise of Massachusetts General Hospital specialists to many more patients with Down syndrome (DS), according to a study published today in Genetics in Medicine.
Recent shortages of vaccines, most recently the flu vaccine during the past winter, are not short-term glitches-they reflect long-term problems in the vaccine industry. A variety of social, legal and economic forces have caused pharmaceutical companies to withdraw their commitment to vaccines, according to pediatrician and vaccine expert Paul A. Offit, M.D., chief of Infectious Diseases at The Children's Hospital of Philadelphia.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that the Company entered into a share transfer agreement with Devont Asset Management Limited on January 15th 2013 to sell an approximately 35% equity interest in Shanghai Celgen Bio-Pharmaceutical Co., Ltd. for a cash consideration of RMB 302 million.
› Verified 7 days ago